Get started
Author

Amine Belhabri

Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)
2000 · M Michallet, X Thomas, et al. · Bone Marrow Transplantation · 159
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
2020 · Souad Assaad, Virginie Avrillon, et al. · European Journal of Cancer · 125
PDF
Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis
2000 · A. Thiébaut, X. Thomas, et al. · Annals of Hematology · 90
Targeting apoptosis in acute myeloid leukaemia
2017 · Philippe A Cassier, Marie Castets, et al. · British Journal of Cancer · 86
PDF
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial
2010 · T. de Witte, A. Hagemeijer, et al. · Haematologica · 75
PDF
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial
2003 · S Keating, S Suciu, et al. · Leukemia · 64
PDF
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia
1999 · E Archimbaud, U Jehn, et al. · Leukemia · 62
Influence of cigarette smoking on the presentation and course of acute myeloid leukemia
2002 · Y. Chelghoum, C. Danaïla, et al. · Annals of Oncology · 60
PDF
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
2018 · Eric Van Den Neste, Marc André, et al. · Haematologica · 55
PDF
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
2024 · Patrice Chevallier, Thibaut Leguay, et al. · Journal of Clinical Oncology · 49
Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features
2002 · Christiane Charrin, Amine Belhabri, et al. · The Hematology Journal · 47
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
2003 · M Oosterveld, S Suciu, et al. · Leukemia · 45
A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome
2018 · Thibault Voeltzel, Mario Flores-Violante, et al. · Cell Death and Disease · 44
PDF
Improving Diagnosis of Pulmonary Mucormycosis
2023 · Anne Coste, Anne Conrad, et al. · CHEST Journal · 43
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial
2002 · Amine Belhabri, Xavier Thomas, et al. · The Hematology Journal · 41
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
2021 · J.E. Martin, S. Khalife-Hachem, et al. · Annals of Oncology · 35
PDF
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia
2024 · Yves Chalandon, Philippe Rousselot, et al. · Blood · 34
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
2021 · P. Heudel, S. Chabaud, et al. · ESMO Open · 32
PDF
Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended
2014 · Sarah Huet, Pascale Cony-Makhoul, et al. · PLoS ONE · 32
PDF
Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation
1998 · M Michallet, F Persat, et al. · Bone Marrow Transplantation · 31
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience
2022 · Vincent Marmouset, Justine Decroocq, et al. · Clinical Cancer Research · 30
PDF
Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B Study
2022 · Nicolas Boissel, Francoise Huguet, et al. · Blood · 29
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment
2024 · Sylvain Garciaz, Pierre‐Yves Dumas, et al. · American Journal of Hematology · 25
PDF
Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: A retrospective study of 54 cases
2001 · A. Colita, A. Belhabri, et al. · Annals of Oncology · 21
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation
1999 · M Michallet, M-C Perrin, et al. · Bone Marrow Transplantation · 21
Works count: 148
Citation count: 1,695
H-index: 24
I10-index: 37
Year
Topic
Type